Related Experiment Video
Updated: Sep 4, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic
Xiangbin Meng1, Xu-Liang Wang2,1, Zhi-Yuan Zhang3
1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.
Insights
Thyroid dysfunction increases atrial fibrillation risk in hypertrophic obstructive cardiomyopathy (HOCM) patients. Both high and low thyroid-stimulating hormone (TSH) levels are linked to higher AF incidence.
Area of Science:
- Cardiology
- Endocrinology
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is a significant cardiovascular condition.
- Atrial fibrillation (AF) is a common complication in HOCM patients.
- The role of thyroid dysfunction in AF development within HOCM is not fully understood.
Purpose of the Study:
- To investigate the association between thyroid dysfunction and the incidence of atrial fibrillation (AF) in patients diagnosed with hypertrophic obstructive cardiomyopathy (HOCM).
Main Methods:
- Thyroid function tests were performed on 755 HOCM patients.
- Patients were stratified into four groups based on thyroid-stimulating hormone (TSH) levels.
- Statistical analysis, including logistic regression, was used to determine correlations.
Main Results:
- The overall incidence of AF in the HOCM cohort was 14%.
- Patients with AF exhibited older age, higher NT-proBNP, elevated creatinine, larger left atrial diameter, lower FT3, and higher FT4 levels.
- Both subnormal (<0.55 mIU/L) and elevated (≥2.50 mIU/L) TSH levels were associated with a significantly increased incidence of AF compared to euthyroid levels (0.55-2.49 mIU/L).
Conclusions:
- Thyroid dysfunction, characterized by abnormal TSH levels, is significantly associated with an increased risk of developing atrial fibrillation in patients with HOCM.
- These findings highlight the importance of monitoring thyroid function in HOCM patients to potentially mitigate AF risk.
Objective:
To explore the correlation between the incidence of atrial fibrillation (AF) and thyroid dysfunction in patients with hypertrophic obstructive cardiomyopathy (HOCM).
Methods:
Thyroid function testing in 755 consecutive patients with HOCM were examined at the National Center for Cardiovascular Diseases (China) from October 2009 to December 2013. Patients were divided into four groups according to the TSH levels: TSH<0.55 mIU/L(n=37)、0.55~2.49 mIU/L (n=490)、2.50~9.9 mIU/L (n=211) and >10.00mIU/L(n=17).
Results:
A total of 107 patients were diagnosed with AF (14%).(1) Compared to HOCM patients without AF,HOCM patients with AF have older age (P<0.001), higher NT-proBNP (P=0.002), higher Cr (P=0.005), larger left atrial diameter(P=0.001), lower FT3 (P=0.046), higher FT4 (P=0.004).(2) In the four groups according to the TSH levels: TSH<0.55 mIU/L, 0.55~2.49mIU/L, 2.50~9.9mIU/L and ≥10.00mIU/L, the incidence of AF was 27.02%(10/37),10.20%(50/490), 19.43%(41/211), and 35.29%(6/17), respectively. Both high and low TSH levels were associated with an increased incidence of AF. After adjusting for the common risk factor (age, NT-proBNP, and so on), stepwise multiple logistic regression analysis revealed that TSH levels were significantly related to AF incidence.Compared to patients with TSH 0.55~2.49 mlU/L, the adjusted odds ratio of AF for TSH<0.55, 2.50~9.99, ≥10.00 mIU/L were 1.481 (95% CI 0.485~4.518,P=0.490), 1.977 (95%CI 1.115~3.506, p=0.02), 4.301 (95%CI 1.059~17.476, P=0.041), respectively.
Conclusion:
Our results suggested that thyroid dysfunction was associated with an increased risk of AF in patients with HOCM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Rheumatic Heart Disease I: Introduction
Heart Failure I: Introduction
Cardiomyopathy V: Interprofessional Care
Mechanism of Cardiac Arrhythmias

